StreetAlpha.app
Home › Stocks › ELMD

Electromed, Inc. (ELMD)

$22.98
▼ −1.20%
LAST CLOSE · NOV 20

Electromed makes the SmartVest airway clearance system, a home and hospital device for people with compromised lung function. It last closed at $22.98 on Nov 20, down 1.20% on the day. The next earnings report for ELMD is expected around Tue, Feb 9, 2027, after the close. For the quarter ended Sep 2026, ELMD reported EPS of $0.32 on revenue of $18.7M, with revenue up 10.6% from a year ago. Over its last 8 reports the stock moved an average of 14.4% the session after earnings. Over the last 12 months ELMD insiders bought $0 of stock on the open market and sold $2.2M, according to SEC Form 4 filings.

AI Auto Pilots
Is ELMD in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ELMD.

Key Stats

Last 12 months
Results
Revenue
$75.6M
+14.1% vs a year ago
Net income
$11.9M
+45.5% vs a year ago
EPS (diluted)
$1.37
+45.7% vs a year ago
Free cash flow
$8.7M
11.5% margin
Valuation
Market cap
$187.8M
8.2M shares
P/E
16.8
Price over 12 month EPS
Price to sales
2.5
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$15.9M
At Sep 30
Shareholder equity
$52.5M
Buybacks
$7.2M
Last 12 months
Fiscal year endsJune
ExchangeNYSE
Financials history
FY2022: $41.7M$41.7MFY2022FY2023: $48.1M$48.1MFY2023FY2024: $54.7M$54.7MFY2024FY2025: $64.0M$64.0MFY2025FY2026: $73.8M$73.8MFY2026

From ELMD's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 10). Last 12 months adds up the four latest quarters.

Next report
Feb 9
Estimated date · After the close
Reported EPS
$0.32
Quarter ended Sep 2026
Year ago EPS
$0.25
+28.0% on a GAAP basis
Revenue
$18.7M
+10.6% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.22Dec '24Mar 2025: $0.21Mar '25Jun 2025: $0.26Jun '25Sep 2025: $0.25Sep '25Dec 2025: $0.32Dec '25Mar 2026: $0.35Mar '26Jun 2026: $0.39Jun '26Sep 2026: $0.32Sep '26Latest $0.32
Revenue by quarter
Dec 2024: $16.3MDec '24Mar 2025: $15.7MMar '25Jun 2025: $17.4MJun '25Sep 2025: $16.9MSep '25Dec 2025: $18.9MDec '25Mar 2026: $18.6MMar '26Jun 2026: $19.4MJun '26Sep 2026: $18.7MSep '26Latest $18.7M
How ELMD moved after its last 8 reports
Average move the session after a report ±14.4%
Nov 10, 2026After the close−8.2%
Aug 25, 2026After the close−19.2%
May 12, 2026After the close+25.1%
Feb 10, 2026After the close−10.0%
Nov 12, 2025After the close+3.8%
Aug 26, 2025After the close+19.9%
May 13, 2025After the close−15.3%
Feb 11, 2025After the close+14.0%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on ELMDStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on ELMD
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on ELMD

Technical Analysis

ELMD · as of the Nov 20 close · updated each morning
Downtrend, oversold

The stock is 12% below its 20 day and 17% below its 50 day average. It is 35% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 27), oversold. The nearest support is the Pivot S1 at $22.83, and the nearest resistance the Pivot at $23.03.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 4.9%/day
Key levels
$47.4052 week high+106.3%
$32.70100 day average+42.3%
$31.03200 day average+35.0%
$28.00Swing high (Nov 11)+21.8%
$26.8150 day average+16.7%
$25.7520 day average+12.1%
$23.18Pivot R1+0.9%
$23.03Pivot+0.2%
$22.98Last close
$22.83Pivot S1−0.7%
$22.6752 week low−1.3%
$22.67Swing low (Nov 16)−1.3%
Indicators
RSI (14)26.93Oversold below 30Oversold
MACD-1.24Below its signal lineBearish
Stochastic10.0Near the bottom of its rangeOversold
ADX (14)28.1Trending down
Williams %R-94.3Oversold below −80, overbought above −20Oversold
CCI (20)-123.0Oversold below −100, overbought above 100Oversold
Rate of change−15.4%Change over 10 sessionsBearish
ATR (14)$1.13Typical daily range, 4.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for ELMD

What happened before

See how ELMD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow ELMD usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How ELMD has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2010.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for ELMDHow many large options trades hit ELMD, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

ELMD Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲69 buying vs 50 selling
  • ▲Held by funds +2.5 pts
  • ▼Funds holding -3
  • ▼Superinvestors: 1 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding126129−2.3%
In funds' top 10110.0%
Held by funds59.4%56.9%+2.5 pts
New / increased20 / 4933 / 41−6.8%
Reduced / sold out26 / 2432 / 7+28.2%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ELMD institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

ELMD Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$2.2M3 sales · 3 insiders
2026-05 sold $1.4M2026-06 sold $783KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Jun 8James L. CunniffCEO and PresidentSale9,700$36.50$354K
Jun 4Bradley M. NagelCFOSale11,801$36.35$429K
May 15Kathleen SkarvanDirectorSale40,000$35.48$1.4M
Sep 11, 2025Andrew SummersDirectorSale65,714$24.32$1.6M
Feb 24, 2025Andrew SummersDirectorSale111,475$27.99$3.1M
Feb 18, 2025Kathleen SkarvanDirectorSale76,583$30.48$2.3M
Every insider buy and sale for ELMD over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See ELMD insider trades →

From SEC Form 4 filings by ELMD's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ELMD is in one of them and how their past ELMD trades turned out.

ELMD in the AI portfolios
Loading…

ELMD News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ELMD in an article yet. Here's the latest on the wider market.

ELMD in the news

About Electromed

Electromed makes the SmartVest Airway Clearance System, a device that uses air pulses to loosen and move mucus out of the lungs for people with compromised lung function. The company is based in New Prague, Minnesota. Its products are prescribed by physicians and sold into the home health care market and to hospitals, with patients including people with bronchiectasis, cystic fibrosis and neuromuscular conditions. Electromed sells directly to patients and clinicians, handling referrals, insurance billing and home training.

Headquarters
New Prague, MN